UTHR vs. SRPT
Compare and contrast key facts about United Therapeutics Corporation (UTHR) and Sarepta Therapeutics, Inc. (SRPT).
Performance
UTHR vs. SRPT - Performance Comparison
Loading graphics...
UTHR vs. SRPT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 21.70% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 3.15% |
SRPT Sarepta Therapeutics, Inc. | 1.12% | -82.30% | 26.09% | -25.58% | 43.90% | -47.18% | 32.12% | 18.24% | 96.14% | 102.84% |
Fundamentals
UTHR:
$28.40B
SRPT:
$2.28B
UTHR:
$27.90
SRPT:
-$8.11
UTHR:
8.91
SRPT:
1.03
UTHR:
4.00
SRPT:
2.00
UTHR:
$3.18B
SRPT:
$2.20B
UTHR:
$2.80B
SRPT:
-$1.05B
UTHR:
$1.82B
SRPT:
-$778.95M
Returns By Period
In the year-to-date period, UTHR achieves a 21.70% return, which is significantly higher than SRPT's 1.12% return. Over the past 10 years, UTHR has outperformed SRPT with an annualized return of 18.04%, while SRPT has yielded a comparatively lower 0.86% annualized return.
UTHR
- 1D
- 0.79%
- 1M
- 17.68%
- YTD
- 21.70%
- 6M
- 41.45%
- 1Y
- 92.36%
- 3Y*
- 38.34%
- 5Y*
- 25.25%
- 10Y*
- 18.04%
SRPT
- 1D
- 6.25%
- 1M
- 29.83%
- YTD
- 1.12%
- 6M
- 12.92%
- 1Y
- -65.90%
- 3Y*
- -45.95%
- 5Y*
- -22.17%
- 10Y*
- 0.86%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UTHR vs. SRPT — Risk / Return Rank
UTHR
SRPT
UTHR vs. SRPT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UTHR | SRPT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.84 | -0.60 | +2.44 |
Sortino ratioReturn per unit of downside risk | 3.30 | -0.47 | +3.77 |
Omega ratioGain probability vs. loss probability | 1.46 | 0.93 | +0.53 |
Calmar ratioReturn relative to maximum drawdown | 5.70 | -0.85 | +6.55 |
Martin ratioReturn relative to average drawdown | 14.49 | -1.09 | +15.58 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| UTHR | SRPT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.84 | -0.60 | +2.44 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.72 | -0.32 | +1.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.51 | 0.01 | +0.50 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | -0.02 | +0.41 |
Correlation
The correlation between UTHR and SRPT is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
UTHR vs. SRPT - Dividend Comparison
Neither UTHR nor SRPT has paid dividends to shareholders.
Drawdowns
UTHR vs. SRPT - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, smaller than the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for UTHR and SRPT.
Loading graphics...
Drawdown Indicators
| UTHR | SRPT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.18% | -98.17% | +4.99% |
Max Drawdown (1Y)Largest decline over 1 year | -16.35% | -81.26% | +64.91% |
Max Drawdown (5Y)Largest decline over 5 years | -33.00% | -92.72% | +59.72% |
Max Drawdown (10Y)Largest decline over 10 years | -55.56% | -93.33% | +37.77% |
Current DrawdownCurrent decline from peak | 0.00% | -87.83% | +87.83% |
Average DrawdownAverage peak-to-trough decline | -35.53% | -68.01% | +32.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.43% | 63.49% | -57.06% |
Volatility
UTHR vs. SRPT - Volatility Comparison
The current volatility for United Therapeutics Corporation (UTHR) is 17.05%, while Sarepta Therapeutics, Inc. (SRPT) has a volatility of 35.20%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| UTHR | SRPT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.05% | 35.20% | -18.15% |
Volatility (6M)Calculated over the trailing 6-month period | 26.84% | 70.73% | -43.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.41% | 110.30% | -59.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.89% | 69.77% | -33.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.32% | 75.48% | -40.16% |
Financials
UTHR vs. SRPT - Financials Comparison
This section allows you to compare key financial metrics between United Therapeutics Corporation and Sarepta Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities